150 related articles for article (PubMed ID: 17082007)
1. Hematopoietic and endothelial progenitor cell trafficking in patients with myeloproliferative diseases.
Oppliger Leibundgut E; Horn MP; Brunold C; Pfanner-Meyer B; Marti D; Hirsiger H; Tobler A; Zwicky C
Haematologica; 2006 Nov; 91(11):1465-72. PubMed ID: 17082007
[TBL] [Abstract][Full Text] [Related]
2. Progenitor cell trafficking in physiologic conditions and in myeloproliferative diseases: quantification of CD34+ cells by polymerase chain reaction.
Oppliger Leibundgut E; Brunold C; Marti D; Horn MP; Seiler C; Schroeder V; Schmid JP; Tobler A; Zwicky C
Haematologica; 2005 Jul; 90(7):875-80. PubMed ID: 15996924
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders.
Passamonti F; Vanelli L; Malabarba L; Rumi E; Pungolino E; Malcovati L; Pascutto C; Morra E; Lazzarino M; Cazzola M
Haematologica; 2003 Oct; 88(10):1123-9. PubMed ID: 14555308
[TBL] [Abstract][Full Text] [Related]
4. The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disorders.
Michiels JJ; De Raeve H; Berneman Z; Van Bockstaele D; Hebeda K; Lam K; Schroyens W
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):307-40. PubMed ID: 16810609
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of circulating endothelial cells, VEGF and VEGFR2 serum levels in patients with chronic myeloproliferative diseases.
Alonci A; Allegra A; Bellomo G; Penna G; D'Angelo A; Quartarone E; Musolino C
Hematol Oncol; 2008 Dec; 26(4):235-9. PubMed ID: 18504767
[TBL] [Abstract][Full Text] [Related]
6. WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders.
Michiels JJ; De Raeve H; Hebeda K; Lam KH; Berneman Z; Schroyens W; Schwarz J
Leuk Res; 2007 Aug; 31(8):1031-8. PubMed ID: 17367853
[TBL] [Abstract][Full Text] [Related]
7. The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disorders.
Larsen TS; Christensen JH; Hasselbalch HC; Pallisgaard N
Br J Haematol; 2007 Mar; 136(5):745-51. PubMed ID: 17313377
[TBL] [Abstract][Full Text] [Related]
8. Endothelial and myogenic differentiation of hematopoietic progenitor cells in inflammatory myopathies.
Hollemann D; Budka H; Löscher WN; Yanagida G; Fischer MB; Wanschitz JV
J Neuropathol Exp Neurol; 2008 Jul; 67(7):711-9. PubMed ID: 18596542
[TBL] [Abstract][Full Text] [Related]
9. Distinct gene expression pattern of malignant hematopoietic stem and progenitor cells in polycythemia vera.
Steidl U; Schroeder T; Steidl C; Kobbe G; Graef T; Bork S; Pechtel S; Kliszewski S; Kuendgen A; Rohr UP; Fenk R; Schroeder M; Haase D; Haas R; Kronenwett R
Ann N Y Acad Sci; 2005 Jun; 1044():94-108. PubMed ID: 15958702
[TBL] [Abstract][Full Text] [Related]
10. Increased levels of circulating endothelial progenitor cells and circulating endothelial nitric oxide synthase in patients with gliomas.
Zheng PP; Hop WC; Luider TM; Sillevis Smitt PA; Kros JM
Ann Neurol; 2007 Jul; 62(1):40-8. PubMed ID: 17503506
[TBL] [Abstract][Full Text] [Related]
11. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
[TBL] [Abstract][Full Text] [Related]
12. Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection.
Lemoli RM; Catani L; Talarico S; Loggi E; Gramenzi A; Baccarani U; Fogli M; Grazi GL; Aluigi M; Marzocchi G; Bernardi M; Pinna A; Bresadola F; Baccarani M; Andreone P
Stem Cells; 2006 Dec; 24(12):2817-25. PubMed ID: 16931769
[TBL] [Abstract][Full Text] [Related]
13. Enhanced generation of endothelial cells from CD34+ cells of the bone marrow in rheumatoid arthritis: possible role in synovial neovascularization.
Hirohata S; Yanagida T; Nampei A; Kunugiza Y; Hashimoto H; Tomita T; Yoshikawa H; Ochi T
Arthritis Rheum; 2004 Dec; 50(12):3888-96. PubMed ID: 15593185
[TBL] [Abstract][Full Text] [Related]
14. Mobilized human CD34+ hematopoietic stem cells enhance tumor growth in a nonobese diabetic/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma.
de Bont ES; Guikema JE; Scherpen F; Meeuwsen T; Kamps WA; Vellenga E; Bos NA
Cancer Res; 2001 Oct; 61(20):7654-9. PubMed ID: 11606408
[TBL] [Abstract][Full Text] [Related]
15. [Activation of signal transducers and activators of transcription induced by vascular endothelial growth factor in CD34+ hematopoietic progenitor cells in vitro].
Ye F; Ye DF; Xie X; Chen HZ; Lü WG
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):12-7. PubMed ID: 15052767
[TBL] [Abstract][Full Text] [Related]
16. Circulating CD34+/KDR+ endothelial progenitor cells are reduced in chronic heart failure patients as a function of Type D personality.
Van Craenenbroeck EM; Denollet J; Paelinck BP; Beckers P; Possemiers N; Hoymans VY; Vrints CJ; Conraads VM
Clin Sci (Lond); 2009 Jul; 117(4):165-72. PubMed ID: 19173675
[TBL] [Abstract][Full Text] [Related]
17. Structural, antigenetic and transcriptional characteristics in peripheral blood CD34+ progenitor cells from polycythemia vera patients: evidence for delayed determination.
Wickenhauser C; Pérez F; Siebolts U; Lorenzen J; Varus E; Frimpong S; Thiele J
Int J Oncol; 2003 Aug; 23(2):437-43. PubMed ID: 12851693
[TBL] [Abstract][Full Text] [Related]
18. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
[TBL] [Abstract][Full Text] [Related]
19. The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotype.
Larsen TS; Pallisgaard N; Møller MB; Hasselbalch HC
Eur J Haematol; 2007 Dec; 79(6):508-15. PubMed ID: 17961178
[TBL] [Abstract][Full Text] [Related]
20. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
